ATXS vs NI · rev $706.0K vs P/E 23, rev $3.61B
Astria Therapeutics Inc (ATXS) versus NiSource Inc (NI) — a side-by-side from cached financials, not a winner call.
Astria Therapeutics Inc (ATXS) is a biotechnology company listed on US.
NiSource Inc (NI) is a utilities - regulated gas company listed on NYSE.
Latest reported ATXS revenue for 2025-09-30 was $706.0K. Net income was -$98.4M. ATXS currently screens at market cap $382.1M.
Latest reported NI revenue for 2026-06-30 was $3.61B. Net income was $552.6M. Revenue was up 55.5% from 2026-03-31 to 2026-06-30. NI currently screens at market cap $22.42B and trailing P/E 23.3.
ATXS currently screens at market cap $382.1M. NI currently screens at market cap $22.42B and trailing P/E 23.3.
Not investment advice. Open the ATXS and NI stock pages for the full models.
Not investment advice.